The Netherlands Journal of Critical Care, an esteemed publication of the NETHERLANDS SOC INTENSIVE CARE, serves as a vital resource for those in the fields of critical care and intensive medicine. As a platform focused on disseminating high-quality research from 2008 to 2023, this journal provides critical insights and advancements pertinent to the rapidly evolving landscape of intensive care practices. Though categorized in the fourth quartile for Critical Care and Intensive Care Medicine in 2023, its commitment to enhancing patient outcomes remains unwavering. With an ISSN of 1569-3511, this journal invites submissions that push the boundaries of knowledge and offer innovative approaches to critical care challenges. Thus, it is an essential reference for researchers, healthcare professionals, and students eager to stay at the forefront of critical care developments in the Netherlands and beyond.

Journal of Acute Disease is a leading peer-reviewed publication dedicated to the timely dissemination of research focused on acute medical conditions, enhancing our understanding and management of these vital health issues. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, this Open Access journal has been committed to providing unrestricted access to high-quality research since its establishment in 2012, ensuring that professionals, researchers, and students can readily benefit from groundbreaking studies and innovative practices in the field. With a focus on enhancing clinical practice through rigorous research, the journal covers a wide range of topics including epidemiology, diagnostics, treatment protocols, and patient outcomes related to acute diseases. With its robust editorial team and a global readership, the Journal of Acute Disease serves as an essential platform for advancing knowledge and improving healthcare delivery worldwide.

Respiratory Care is a leading journal in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, published by DAEDALUS ENTERPRISES INC. With a history dating back to 1973 and continuing through 2024, this journal serves as a vital platform for disseminating innovative research findings, clinical practices, and advancements in respiratory healthcare. The journal is recognized for its impact, reflected in its impressive Q2 quartile rankings across several categories in 2023, demonstrating its relevance and influence in the medical community. Although it is not an Open Access publication, it provides critical insights and foster discussions aimed at enhancing patient care and treatment protocols for respiratory diseases. The journal is indexed in notable databases, ensuring wide visibility and accessibility of its content to researchers, professionals, and students dedicated to advancing knowledge and practice in respiratory care.

Medicina Intensiva is a distinguished journal published by Elsevier España SLU, specializing in the critical care and intensive medicine fields. Since its inception in 1988, this peer-reviewed journal has established itself as a vital resource for healthcare professionals and researchers dedicated to advancing the knowledge and treatment of critically ill patients. With an impact factor ranked in the Q2 category for Critical Care and Intensive Care Medicine, the journal sits at the 50th percentile among its peers, reflecting its reputable standing in the academic community. The scope of the journal encompasses a wide array of topics, from clinical practices to innovative research findings, contributing significantly to the enhancement of patient care in intensive settings. Although the journal does not currently offer Open Access options, its valuable content is accessible to subscribers and institutions, reinforcing its role as an important conduit for disseminating high-quality research. As we continue into 2024, *Medicina Intensiva* remains committed to supporting the medical community through insightful articles and timely reviews that shape the future of intensive care.

The Journal of Critical & Intensive Care, published by the esteemed Soc Turkish Intensivists - STI, serves as a vital platform for advancing knowledge and research in the evolving fields of critical care and intensive medicine. Since its inception in 2020, this journal has focused on disseminating high-quality research that addresses the complexities and challenges faced in the intensive care units, positioning itself as a critical resource for healthcare professionals, researchers, and students in Turkey and beyond. Although currently categorized in the Q4 quartile for Critical Care and Intensive Care Medicine, with a Scopus rank of 99 out of 110, the journal is rapidly gaining attention for its scholarly contributions. With an ongoing commitment to open access principles, it aims to enhance accessibility to groundbreaking studies and reviews, promoting collaborative progress in the critical care domain. The Journal of Critical & Intensive Care is not just a publication; it is a catalyst for innovation and knowledge-sharing critical to improving patient outcomes in intensive care settings.

Annals of Clinical and Analytical Medicine, published by BAYRAKOL MEDICAL PUBLISHER, is a premier open-access journal dedicated to advancing the field of clinical and analytical medicine. With the evolving landscape of healthcare, this journal serves as a crucial platform for the publication of high-quality research that encompasses a wide range of topics in medical science, offering insights into innovative clinical practices and analytical methodologies. The journal, identifiable by its E-ISSN 2667-663X, promotes the dissemination of knowledge by providing unrestricted access to its articles, thus ensuring that researchers, healthcare professionals, and students can stay abreast of the latest findings and developments. As it continues to gain recognition, Annals of Clinical and Analytical Medicine aims to foster an inclusive dialogue within the global medical community, encouraging collaboration and promoting high-impact research that addresses pressing healthcare challenges.

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

Current Opinion in Critical Care, published by Lippincott Williams & Wilkins, is a leading journal in the field of Critical Care and Intensive Care Medicine. With an ISSN of 1070-5295 and an E-ISSN of 1531-7072, this esteemed journal has been committed to disseminating high-quality and impactful research since its inception in 1996. The journal proudly ranks in the top quartile (Q1) of its category for 2023, affirming its position among the premier publications in critical care, with a Scopus ranking of #25 out of 110, placing it in the 77th percentile. Current Opinion in Critical Care offers essential insights, reviews, and discussions on the latest trends and best practices in the field, catering to the needs of researchers, clinicians, and students alike. Though it does not provide open access options, its contributions are pivotal in shaping patient care approaches and advancing clinical outcomes in critical care settings.

The Journal of Intensive Care, published by BMC, is a leading open access journal dedicated to advancing research and knowledge in the fields of critical care and intensive care medicine. With an impressive 2023 rank of #11 out of 110 in its category and placing in the 90th percentile, this journal offers a vital platform for researchers, clinicians, and healthcare professionals to disseminate innovative findings and best practices. Launched in 2013, the journal has gained significant recognition, achieving a Q1 quartile ranking in critical care, reflecting its commitment to high-quality contributions that address pressing issues in patient management and care. Additionally, as an open access publication, the journal ensures that its content is widely accessible, fostering collaboration and knowledge sharing within the global medical community. For those engaged in intensive care, the Journal of Intensive Care is an essential resource for staying abreast of the latest research trends and clinical advancements.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.